ScreenerHero

YDES YD Bio Ltd

NAS · US · Healthcare · Biotechnology · ydesgroup.com
7.110USD-12.33%Mkt Cap: 503.61M $P/E: —

YD Bio Limited, a biopharmaceutical company, focuses on regulated diagnostics, life science clinical services, and healthcare product commercialization in the United States and Taiwan. The company offers eye disease trea…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.54BUSDP/E 29.3
MRNA
Moderna, Inc.
$81.13BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$74.79BUSDP/E 18.0
ARGX
argenx SE
$57.11BUSDP/E 34.8
ARGX
argenx SE
$55.24BUSDP/E 36.1
RVMD
Revolution Medicines, Inc.
$44.51BUSD
UCB
UCB SA
$41.63BUSDP/E 17.7
ONC
BeOne Medicines AG
$41.14BUSDP/E 64.7
RPRX
Royalty Pharma plc
$32.74BUSDP/E 30.1
ALNY
Alnylam Pharmaceuticals, Inc.
$29.42BUSDP/E 37.1
ROIV
Roivant Sciences Ltd.
$25.84BUSD
BNTX
BioNTech SE
$24.53BUSD
GMAB
Genmab A/S
$24.01BUSDP/E 30.3
INCY
Incyte Corporation
$23.13BUSDP/E 14.5
INSM
Insmed Incorporated
$22.67BUSD
GMAB
Genmab A/S
$21.61BUSDP/E 29.3
JAZZ
Jazz Pharmaceuticals plc
$15.32BUSDP/E 16.2
ASND
Ascendis Pharma A/S
$15.01BUSDP/E 17.5
EXEL
Exelixis, Inc.
$14.58BUSDP/E 18.6
SMMT
Summit Therapeutics Inc.
$13.78BUSD

Key Statistics

Company
Market Cap503.61M USD
Enterprise Value571.88M USD
Revenue (TTM)1.24M USD
Gross Profit167.41K USD
Net Income (TTM)-8.31M USD
Revenue/Share0.02 USD
Last Price7.110 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees13
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-90.17
EV/Revenue461.45
P/S463.52
P/B1.77
EPS (TTM)-0.04
EPS (Forward)—
52W Range
1.70027% of range22.00
52W High22.00 USD
52W Low1.700 USD
Profitability
Gross Margin28.05%
Oper. Margin-382.12%
EBITDA Margin0.00%
Profit Margin-1392.61%
ROE291.05%
ROA-60.32%
Growth
Revenue Growth314.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.60M USD
CapEx (TTM)1.44M USD
FCF Margin—
FCF Yield—
Net Debt-2.66M USD
Net Debt/EBITDA0.42
Balance Sheet
Debt/Equity-0.00
Current Ratio5.23
Quick Ratio2.70
Book Value/Sh4.57 USD
Cash/Share0.04 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.70.83M
Float16.20M
Insiders80.15%
Institutions0.40%
Short Interest
Short Ratio0.1d
Short % Float0.26%
Short % Out.0.06%
Shares Short42.96K
Short (prev mo.)17.17K
Technical
SMA 503.833 (+85.5%)
SMA 2006.137 (+15.8%)
Beta-0.03
S&P 52W Chg14.58%
Avg Vol (30d)535.38K
Avg Vol (10d)711.22K
Technical Indicators
RSI (14)66.0
MACD1.0719
MACD Signal0.6898
MACD Hist.+0.3821
BB Upper8.688 USD
BB Middle4.917 USD
BB Lower1.146 USD
BB Width153.40%
ATR (14)1.014 USD
Vol Ratio (20d)0.38x